Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6684 |
Remote Similarity |
NPD1233 |
Suspended |
0.6604 |
Remote Similarity |
NPD5072 |
Discontinued |
0.6599 |
Remote Similarity |
NPD1641 |
Discontinued |
0.6526 |
Remote Similarity |
NPD7465 |
Suspended |
0.6498 |
Remote Similarity |
NPD2813 |
Phase 3 |
0.6498 |
Remote Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6438 |
Remote Similarity |
NPD8105 |
Discontinued |
0.6436 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6409 |
Remote Similarity |
NPD5827 |
Discontinued |
0.6351 |
Remote Similarity |
NPD6718 |
Discontinued |
0.6347 |
Remote Similarity |
NPD5524 |
Approved |
0.6347 |
Remote Similarity |
NPD5523 |
Approved |
0.6337 |
Remote Similarity |
NPD1308 |
Approved |
0.6325 |
Remote Similarity |
NPD8375 |
Approved |
0.6319 |
Remote Similarity |
NPD568 |
Approved |
0.6319 |
Remote Similarity |
NPD566 |
Approved |
0.6319 |
Remote Similarity |
NPD567 |
Approved |
0.6286 |
Remote Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6286 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6271 |
Remote Similarity |
NPD8371 |
Clinical (unspecified phase) |
0.6255 |
Remote Similarity |
NPD8291 |
Clinical (unspecified phase) |
0.6215 |
Remote Similarity |
NPD7103 |
Approved |
0.6201 |
Remote Similarity |
NPD8119 |
Discontinued |
0.6199 |
Remote Similarity |
NPD7471 |
Discontinued |
0.6172 |
Remote Similarity |
NPD8641 |
Approved |
0.6154 |
Remote Similarity |
NPD4950 |
Approved |
0.615 |
Remote Similarity |
NPD8629 |
Discontinued |
0.6131 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6126 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6117 |
Remote Similarity |
NPD962 |
Phase 3 |
0.6094 |
Remote Similarity |
NPD8409 |
Suspended |
0.6091 |
Remote Similarity |
NPD7182 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD3432 |
Approved |
0.6071 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.6066 |
Remote Similarity |
NPD875 |
Clinical (unspecified phase) |
0.6043 |
Remote Similarity |
NPD6708 |
Discontinued |
0.6041 |
Remote Similarity |
NPD2786 |
Discontinued |
0.604 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6009 |
Remote Similarity |
NPD6142 |
Phase 3 |
0.6008 |
Remote Similarity |
NPD7197 |
Approved |
0.6 |
Remote Similarity |
NPD7398 |
Approved |
0.6 |
Remote Similarity |
NPD7397 |
Approved |
0.5991 |
Remote Similarity |
NPD7276 |
Approved |
0.5991 |
Remote Similarity |
NPD7277 |
Approved |
0.5982 |
Remote Similarity |
NPD7980 |
Clinical (unspecified phase) |
0.5952 |
Remote Similarity |
NPD7689 |
Approved |
0.5951 |
Remote Similarity |
NPD963 |
Discontinued |
0.5948 |
Remote Similarity |
NPD8004 |
Discontinued |
0.5935 |
Remote Similarity |
NPD722 |
Clinical (unspecified phase) |
0.5924 |
Remote Similarity |
NPD996 |
Phase 2 |
0.5924 |
Remote Similarity |
NPD7857 |
Phase 3 |
0.5924 |
Remote Similarity |
NPD7856 |
Phase 2 |
0.5924 |
Remote Similarity |
NPD994 |
Phase 2 |
0.5917 |
Remote Similarity |
NPD7486 |
Phase 1 |
0.5913 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.5909 |
Remote Similarity |
NPD7850 |
Discontinued |
0.5909 |
Remote Similarity |
NPD4612 |
Discontinued |
0.5909 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.5901 |
Remote Similarity |
NPD6763 |
Discontinued |
0.5891 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.589 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.5877 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.5876 |
Remote Similarity |
NPD3906 |
Approved |
0.5869 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.5864 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD7767 |
Approved |
0.5857 |
Remote Similarity |
NPD7233 |
Approved |
0.5857 |
Remote Similarity |
NPD7234 |
Approved |
0.5851 |
Remote Similarity |
NPD6460 |
Clinical (unspecified phase) |
0.5845 |
Remote Similarity |
NPD7270 |
Phase 2 |
0.5842 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD6856 |
Discontinued |
0.583 |
Remote Similarity |
NPD949 |
Phase 1 |
0.5826 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.5826 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.5819 |
Remote Similarity |
NPD7694 |
Discontinued |
0.5819 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.5808 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.58 |
Remote Similarity |
NPD5461 |
Discontinued |
0.5798 |
Remote Similarity |
NPD4938 |
Phase 2 |
0.5797 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5797 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5792 |
Remote Similarity |
NPD7834 |
Approved |
0.5789 |
Remote Similarity |
NPD8373 |
Clinical (unspecified phase) |
0.5785 |
Remote Similarity |
NPD8468 |
Phase 2 |
0.5785 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.5783 |
Remote Similarity |
NPD7923 |
Phase 2 |
0.5783 |
Remote Similarity |
NPD6036 |
Suspended |
0.5776 |
Remote Similarity |
NPD8075 |
Discontinued |
0.5773 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.5771 |
Remote Similarity |
NPD8257 |
Approved |
0.5771 |
Remote Similarity |
NPD8256 |
Approved |
0.5766 |
Remote Similarity |
NPD7776 |
Approved |
0.5766 |
Remote Similarity |
NPD7981 |
Discontinued |
0.5762 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.5762 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.5762 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.5753 |
Remote Similarity |
NPD2879 |
Approved |
0.5753 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.5753 |
Remote Similarity |
NPD2881 |
Approved |
0.5753 |
Remote Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.5751 |
Remote Similarity |
NPD7161 |
Clinical (unspecified phase) |
0.5751 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.5746 |
Remote Similarity |
NPD1623 |
Approved |
0.5741 |
Remote Similarity |
NPD6206 |
Phase 1 |
0.5741 |
Remote Similarity |
NPD4953 |
Phase 3 |
0.5738 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.5736 |
Remote Similarity |
NPD1274 |
Clinical (unspecified phase) |
0.5727 |
Remote Similarity |
NPD2412 |
Clinical (unspecified phase) |
0.5726 |
Remote Similarity |
NPD5821 |
Approved |
0.5722 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.5721 |
Remote Similarity |
NPD3839 |
Phase 2 |
0.5721 |
Remote Similarity |
NPD3840 |
Phase 2 |
0.5708 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.5708 |
Remote Similarity |
NPD6992 |
Phase 2 |
0.5708 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.5708 |
Remote Similarity |
NPD4334 |
Discontinued |
0.5702 |
Remote Similarity |
NPD8325 |
Phase 3 |
0.5702 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.5702 |
Remote Similarity |
NPD6218 |
Discontinued |
0.5702 |
Remote Similarity |
NPD8327 |
Clinical (unspecified phase) |
0.5702 |
Remote Similarity |
NPD8326 |
Phase 3 |
0.5701 |
Remote Similarity |
NPD5425 |
Phase 1 |
0.5695 |
Remote Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.5694 |
Remote Similarity |
NPD7061 |
Clinical (unspecified phase) |
0.5692 |
Remote Similarity |
NPD1027 |
Approved |
0.5692 |
Remote Similarity |
NPD1030 |
Approved |
0.5692 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5692 |
Remote Similarity |
NPD8287 |
Phase 1 |
0.5692 |
Remote Similarity |
NPD8288 |
Phase 2 |
0.5691 |
Remote Similarity |
NPD1430 |
Approved |
0.5691 |
Remote Similarity |
NPD1431 |
Approved |
0.5685 |
Remote Similarity |
NPD3697 |
Discontinued |
0.5685 |
Remote Similarity |
NPD8442 |
Discontinued |
0.5685 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5682 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5674 |
Remote Similarity |
NPD460 |
Discontinued |
0.5674 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.5673 |
Remote Similarity |
NPD4896 |
Clinical (unspecified phase) |
0.5672 |
Remote Similarity |
NPD8159 |
Discontinued |
0.5667 |
Remote Similarity |
NPD5107 |
Clinical (unspecified phase) |
0.5663 |
Remote Similarity |
NPD8049 |
Phase 2 |
0.5661 |
Remote Similarity |
NPD8412 |
Phase 1 |
0.5661 |
Remote Similarity |
NPD7860 |
Clinical (unspecified phase) |
0.566 |
Remote Similarity |
NPD7887 |
Approved |
0.566 |
Remote Similarity |
NPD7888 |
Approved |
0.5658 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.5654 |
Remote Similarity |
NPD3785 |
Clinical (unspecified phase) |
0.565 |
Remote Similarity |
NPD1197 |
Approved |
0.565 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.5648 |
Remote Similarity |
NPD4427 |
Phase 2 |
0.5647 |
Remote Similarity |
NPD5907 |
Phase 3 |
0.5644 |
Remote Similarity |
NPD8261 |
Discontinued |
0.5633 |
Remote Similarity |
NPD7996 |
Phase 2 |
0.563 |
Remote Similarity |
NPD7273 |
Clinical (unspecified phase) |
0.563 |
Remote Similarity |
NPD6223 |
Clinical (unspecified phase) |
0.5622 |
Remote Similarity |
NPD4070 |
Clinical (unspecified phase) |
0.562 |
Remote Similarity |
NPD6715 |
Discontinued |
0.5617 |
Remote Similarity |
NPD6164 |
Phase 2 |
0.5617 |
Remote Similarity |
NPD6165 |
Phase 2 |
0.5613 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.5612 |
Remote Similarity |
NPD8316 |
Phase 2 |
0.5612 |
Remote Similarity |
NPD8317 |
Phase 2 |
0.5611 |
Remote Similarity |
NPD5486 |
Discontinued |
0.5609 |
Remote Similarity |
NPD5533 |
Discontinued |
0.5607 |
Remote Similarity |
NPD3870 |
Clinical (unspecified phase) |
0.5607 |
Remote Similarity |
NPD3871 |
Clinical (unspecified phase) |
0.5605 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.5605 |
Remote Similarity |
NPD6732 |
Clinical (unspecified phase) |
0.5605 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.5605 |
Remote Similarity |
NPD2008 |
Discontinued |
0.5604 |
Remote Similarity |
NPD8421 |
Discontinued |
0.5602 |
Remote Similarity |
NPD5176 |
Approved |
0.5602 |
Remote Similarity |
NPD38 |
Approved |
0.56
|
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |